Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...

Sanofi is supercharging its artificial intelligence capabilities. | Sanofi is supercharging its artificial intelligence ...

Kyverna Therapeutics is on the cusp of a historic first: getting a CAR-T therapy approved for an autoimmune disease—and now ...

Robert Blum and Fady Malik, M.D., Ph.D, have been with Cytokinetics since its inception nearly three decades ago. | ...

Created from the merger of Mallinckrodt and Endo last year, Keenova is launching the first Dupuytren's contracture campaign ...

The U.S. Supreme Court has temporarily reinstated online access to the abortion pill mifepristone.  | The U.S. Supreme Court ...

After submitting plans to cut 114 jobs tied to its U.S. headquarters in New Jersey in March, Novartis late last month added a ...

A union strike of thousands of workers is still ongoing at Korean CDMO Samsung Biologics, costing the company over a million ...

Bristol Myers Squibb is warming up for the FIFA World Cup 2026 with a new media campaign, launching its “Won’t Lose” ad ahead ...

After topping up its long-running operations in Puerto Rico with plans for a $650 million investment last year, Amgen is ...

For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor ...

Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...